晚期非小细胞肺癌的免疫疗法与放射疗法相结合:当前状况和挑战 (综述)

Qiong Li1, Ya-Qin Cai1, Li-Hua Shao1

  • 1Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Gansu Provincial Academy of Medical Science, Lanzhou, Gansu 730050, P.R. China.

Oncology letters
|August 13, 2025
PubMed
概括

将免疫疗法与放射疗法结合起来,可以为高级非小细胞肺癌 (NSCLC) 提供协同作用的抗瘤效应. 本综述探讨了这种组合的合理性,有效性和安全性,强调了改善患者结果的潜在好处和挑战.

相关概念视频

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...